Perspective Therapeutics Inc (CATX)

[stealthways]

What could IsoRay be worth?

According to management, the company's current portfolio is able to secure $350 million in a $45 billion addressable market. Any statistic will tell you this market is growing, but let's stay conservative and set the growth at a rate of zero. We go with management estimates, and think IsoRay is able to capture $350 million in revenue at least, which is in our view very conservative. $350 million revenue, with 40 million shares outstanding and a price/sales multiple of 3 (industry average is much higher) translates to a value of $25 per share, or a 30X return on investment.

by Sujan Lahia March 14, 2014